BONUS: Mifepristone On Trial: An Unprecedented Overreach
Public Health On Call · Johns Hopkins Bloomberg School of Public Health
April 11, 202315m 1s
Audio is streamed directly from the publisher (traffic.libsyn.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Dr. Raegan McDonald Mosley, an obstetrician-gynecologist and CEO of Power to Decide, returns to the podcast to talk with Dr. Josh Sharfstein about the Texas case that invalidated FDA approval of the abortion medication mifepristone. They discuss what the ruling might mean in the short term and the broader implications for reproductive health, FDA approval of other drugs, and the field of medicine.